Falls: A Marker of Preclinical AD
| 대상 질환 | Fall, Alzheimer Disease |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | Washington University School of Medicine |
| 상태 | 완료 |
| 참여자 수 | 355 명 |
| 시작일 | 2019년 3월 7일 |
| 완료일 | 2025년 4월 30일 |
| 결과 공개일 | 2026년 7월 22일 |
요약
This longitudinal cohort study investigates cognitively normal participants with and without preclinical Alzheimer disease (AD) in order to examine: (1) the relationship between falls and functional mobility in preclinical stages of AD; and (2) a hypothesized model of central and peripheral mechanism(s) underlying falls and functional mobility in preclinical stages of AD.
Fall Severity
| Cohort | 155 Participants |
|---|---|
| Cohort | 100 Participants |
| Cohort | 79 Participants |
| Cohort | 15 Participants |
| Cohort | 107 Participants |
| Cohort | 59 Participants |
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
- Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
- Technology and Family Thriving Study — University of California, Santa Barbara
- Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation